We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patent Board Issues CRISPR Technology Patents to Harvard and MIT’s Broad Institute
Patent Board Issues CRISPR Technology Patents to Harvard and MIT’s Broad Institute
A U.S. Patent and Trademark Office tribunal that oversees patent disputes has ruled that patents on CRISPR technology belong to Harvard University and the Massachusetts Institute of Technology’s Broad Institute — not to Jennifer Doudna of the University of California, Berkeley, and Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, who were given the Nobel Prize in Chemistry in 2020 for first describing how CRISPR could be used to edit DNA in test-tube environments.